Key result
Acute myocardial infarction was associated with significantly lower EuroQuolVAS scores at one month compared to healthy controls (60.50 vs 74.35, p<0.001), with improvement seen at twelve months.
Why the study?
How does health-related quality of life in patients one and twelve months after acute myocardial infarction compare to healthy controls?
Cohort (n=400)
How does health-related quality of life in patients one and twelve months after acute myocardial infarction compare to healthy controls?
Absolute Event Rate: 60.5% vs 74.35%
p-value: p=<0.001
Quality of life significantly improves from one to twelve months after acute myocardial infarction, with better outcomes in patients treated with percutaneous intervention compared to thrombolytic therapy, though it remains lower than healthy controls.
QoL deficits one month post-AMI may warrant supportive care; leaves open whether interventions accelerate recovery to control levels by twelve months.
INTRODUCTION: Acute myocardial infarction has negative influence on patient's quality of life. The objective of the paper was to assess the health-related quality of life in the patients one month and twelve months after acute myocardial infarction and to compare it with the healthy controls. MATERIAL AND METHODS: A prospective cohort study involved 160 patients aged from 30 to 79 and 240 healthy controls. The health-related quality of life was assessed with the Serbian version of these questionnaires: EuroQuol-5-Dimension and EuroQuolVAS. Angina pectoris was ranked according to the classification of Canadian Cardiovascular Society. Multivariate logistic regression analysis was used. RESULTS: The healthy controls had significantly higher average scores in EuroQuolVAS compared with the patients one month after acute myocardial infarction (74.35 +/- 9.42 vs 60.50 +/- 12.03, p<0.001), as well as twelve months afte acute myocardial infarction (74.35 +/- 9.42 vs 69.83 +/- 12.06, p<0.001). Significantly lower average ranges in EuroQuol-5-Dimension questionnaire and higher quality of life were found twelve months after acute myocardial infarction than one month after acute myocardial infarction (1.41 +/- 0.26 vs 1.53 +/- 0.26, p<0.001). The average ranges of angina pectoris were significantly lower in all the patients twelve months after acute myocardial infarction compared with the first month (0.78 +/- 0.51 vs 0.91 +/- 0.44, p<0.01). The multivariate regression analysis confirmed thrombolytic therapy, percutaneous transluminal angioplasty and age to be important factors influencing health-related quality of life. CONCLUSION: The patients assessed their health condition to be significantly higher twelve months after acute myocardial infarction than one month after it. The health-related quality of life was significantly higher in patients who had undergone the percutaneous intervention than in those who had been treated with the thrombolytic therapy.
No takes yet. Share an insight, caveat, or question.
Rančić et al. (2011) conducted a cohort in acute myocardial infarction (n=400). Acute myocardial infarction vs. Healthy controls was evaluated on EuroQuolVAS score at one month (p=<0.001). Acute myocardial infarction was associated with significantly lower EuroQuolVAS scores at one month compared to healthy controls (60.50 vs 74.35, p<0.001), with improvement seen at twelve months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: